Literature DB >> 33637635

Natural History of "Pure" Primary Lateral Sclerosis.

Anhar Hassan1, Shivam Om Mittal2, William T Hu2, Keith A Josephs2, Eric J Sorenson2, J Eric Ahlskog2.   

Abstract

OBJECTIVE: To assess whether primary lateral sclerosis (PLS), classified as pure when the EMG is normal, converts to amyotrophic lateral sclerosis (ALS) after longitudinal follow-up.
METHODS: Retrospective chart review was performed of patients with pure PLS at Mayo Clinic in Rochester, MN (1990-2016). Inclusion criteria required a normal EMG during the first 4 years of symptoms.
RESULTS: Forty-three patients had pure PLS (25 female, 58%) with a median onset age of 50 years (range 38-78 years) and median follow-up at 9 years' disease duration (range 4-36 years). The ascending paraparesis phenotype (n = 30, 70%) was most common, followed by hemiparetic onset (n = 9, 21%) and bulbar onset (n = 4, 9%). Among the 30 paraparetic-onset cases, bladder symptoms (n = 18, 60%) and dysarthria (n = 15, 50%) were more common than pseudobulbar affect (n = 9, 30%) and dysphagia (n = 8, 27%). By the last follow-up, 17 of 30 (56%) used a cane and 6 (20%) required a wheelchair. The paraparetic variant, compared with hemiparetic and bulbar onset, had the youngest onset (48 vs 56 vs 60 years, respectively; p = 0.02). Five patients died; 1 patient required a feeding tube; and none required permanent noninvasive ventilation. Two patients developed an idiopathic multisystem neurodegenerative disorder, which surfaced after 19 and 20 years. Two patients developed minor EMG abnormalities. The remainder 39 had persistently normal EMGs.
CONCLUSIONS: Pure PLS did not convert to ALS after a median of 9 years' disease duration follow-up in our study population. The ascending paraparetic phenotype was most common, with earlier onset and frequent bladder involvement. After years of pure PLS, <5% develop a more pervasive neurodegenerative disorder.
© 2021 American Academy of Neurology.

Entities:  

Mesh:

Year:  2021        PMID: 33637635      PMCID: PMC8166429          DOI: 10.1212/WNL.0000000000011771

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature.

Authors:  N Le Forestier; T Maisonobe; A Piquard; S Rivaud; L Crevier-Buchman; F Salachas; P F Pradat; L Lacomblez; V Meininger
Journal:  Brain       Date:  2001-10       Impact factor: 13.501

Review 2.  Primary lateral sclerosis.

Authors:  Mike A Singer; Jeffrey M Statland; Gil I Wolfe; Richard J Barohn
Journal:  Muscle Nerve       Date:  2007-03       Impact factor: 3.217

3.  Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis.

Authors:  R P Bruyn; J H Koelman; D Troost; J M de Jong
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154

4.  Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria.

Authors:  C E Pringle; A J Hudson; D G Munoz; J A Kiernan; W F Brown; G C Ebers
Journal:  Brain       Date:  1992-04       Impact factor: 13.501

5.  Primary lateral sclerosis: clinical and laboratory features in 25 patients.

Authors:  Mike A Singer; Suleiman Kojan; Richard J Barohn; Laura Herbelin; Sharon P Nations; Jaya R Trivedi; Carlayne E Jackson; Dennis K Burns; Philip J Boyer; Gil I Wolfe
Journal:  J Clin Neuromuscul Dis       Date:  2005-09

6.  Primary lateral sclerosis: a rare upper-motor-predominant form of amyotrophic lateral sclerosis often accompanied by frontotemporal lobar degeneration with ubiquitinated neuronal inclusions? Report of an autopsy case and a review of the literature.

Authors:  Chun-Feng Tan; Akiyoshi Kakita; Yue-Shan Piao; Koki Kikugawa; Kotaro Endo; Masami Tanaka; Koichi Okamoto; Hitoshi Takahashi
Journal:  Acta Neuropathol       Date:  2003-03-01       Impact factor: 17.088

7.  The natural history of primary lateral sclerosis.

Authors:  P H Gordon; B Cheng; I B Katz; M Pinto; A P Hays; H Mitsumoto; L P Rowland
Journal:  Neurology       Date:  2006-03-14       Impact factor: 9.910

8.  The NEALS primary lateral sclerosis registry.

Authors:  Sabrina Paganoni; Fabiola De Marchi; James Chan; Sara K Thrower; Nathan P Staff; Neil Datta; Yaz Y Kisanuki; Vivian Drory; Christina Fournier; Erik P Pioro; Stephen A Goutman; Nazem Atassi; Maryangel Jeon; Sarah Caldwell; Timothy Mcdonough; Caroline Gentile; Jianing Liu; Michelle Turner; Carol Denny; Kevin Felice; Misty Green; Stephanie Scarberry; Saad Abu-Saleh; Beatrice Nefussy; Debbie Hastings; Sangri Kim; Blake Swihart; Ximena Arcila-Londono; Daniel S Newman; Michael Silverman; Angela Genge; Kristiana Salmon; Lauren Elman; Leo Mccluskey; Kelly Almasy; Marc Gotkine; Kimberly Goslin; Arlena Cummings; Eli K Edwards; Michael Rivner; Kristy Bouchard; Brandy Quarles; Justin Kwan; Matthew Jaffa; Robert Baloh; Peggy Allred; David Walk; Samuel Maiser; Georgios Manousakis; Valerie Ferment; J Americo M Fernandes; Pariwat Thaisetthawatkul; Deborah Heimes; Melissa Phillips; Laura Sams; Melissa Kahler; Alecia Corcoran; Daniel G Larriviere; Sadie Chotto; Gracy Juba
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2020-09-11       Impact factor: 4.092

9.  Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.

Authors:  Jennifer L Whitwell; Nirubol Tosakulwong; Hugo Botha; Farwa Ali; Heather M Clark; Joseph R Duffy; Rene L Utianski; Chase A Stevens; Stephen D Weigand; Christopher G Schwarz; Matthew L Senjem; Clifford R Jack; Val J Lowe; J Eric Ahlskog; Dennis W Dickson; Keith A Josephs
Journal:  Neuroimage Clin       Date:  2019-12-28       Impact factor: 4.881

10.  Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease.

Authors:  Jonathan M Schott; Sebastian J Crutch; Minerva M Carrasquillo; James Uphill; Tim J Shakespeare; Natalie S Ryan; Keir X Yong; Manja Lehmann; Nilufer Ertekin-Taner; Neill R Graff-Radford; Bradley F Boeve; Melissa E Murray; Qurat Ul Ain Khan; Ronald C Petersen; Dennis W Dickson; David S Knopman; Gil D Rabinovici; Bruce L Miller; Aida Suárez González; Eulogio Gil-Néciga; Julie S Snowden; Jenny Harris; Stuart M Pickering-Brown; Eva Louwersheimer; Wiesje M van der Flier; Philip Scheltens; Yolande A Pijnenburg; Douglas Galasko; Marie Sarazin; Bruno Dubois; Eloi Magnin; Daniela Galimberti; Elio Scarpini; Stefano F Cappa; John R Hodges; Glenda M Halliday; Lauren Bartley; Maria C Carrillo; Jose T Bras; John Hardy; Martin N Rossor; John Collinge; Nick C Fox; Simon Mead
Journal:  Alzheimers Dement       Date:  2016-03-15       Impact factor: 21.566

View more
  1 in total

Review 1.  Upper Motor Neuron Disorders: Primary Lateral Sclerosis, Upper Motor Neuron Dominant Amyotrophic Lateral Sclerosis, and Hereditary Spastic Paraplegia.

Authors:  Timothy Fullam; Jeffrey Statland
Journal:  Brain Sci       Date:  2021-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.